Comprehensive genomic profiling for patients with chemotherapy‐naïve advanced cancer

Comprehensive genomic profiling (CGP) testing by next‐generation sequencing has been introduced into clinical practice as part of precision cancer medicine to select effective targeted therapies. However, whether CGP testing at the time of first‐line chemotherapy could be clinically useful is not cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kondo, Tomohiro, Matsubara, Junichi, Quy, Pham Nguyen, Fukuyama, Keita, Nomura, Motoo, Funakoshi, Taro, Doi, Keitaro, Sakamori, Yuichi, Yoshioka, Masahiro, Yokoyama, Akira, Tamaoki, Masashi, Kou, Tadayuki, Hirohashi, Kenshiro, Yamada, Atsushi, Yamamoto, Yoshihiro, Minamiguchi, Sachiko, Nishigaki, Masakazu, Yamada, Takahiro, Kanai, Masashi, Matsumoto, Shigemi, Muto, Manabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780032/
https://www.ncbi.nlm.nih.gov/pubmed/33007138
http://dx.doi.org/10.1111/cas.14674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780032/
https://www.ncbi.nlm.nih.gov/pubmed/33007138
http://dx.doi.org/10.1111/cas.14674

Ejemplares similares